会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 35. 发明授权
    • Amino-acid derivatives, their preparation and their use as
pharmaceuticals
    • 氨基酸衍生物,其制备及其作为药物的用途
    • US4545942A
    • 1985-10-08
    • US597817
    • 1984-04-09
    • Mitsuo NaganoKoichi HiraiKouichi KitamuraKenkichi ShinkaiHiroshi Yasuda
    • Mitsuo NaganoKoichi HiraiKouichi KitamuraKenkichi ShinkaiHiroshi Yasuda
    • A61K31/275A61K20060101A61K31/165A61K31/19A61K31/195A61K31/215A61P35/00A61P37/04C07C20060101C07C67/00C07C253/00C07C255/24C07C255/26C07C255/29C07C255/32C07C255/44C07C255/56C07C255/66C07D317/68C07C121/78
    • C07C255/00
    • New compounds useful as immunoregulatory and antineoplastic agents are amino-acid derivatives of formula: ##STR1## wherein: n is an integer from 1 to 5;R.sup.1 is a hydrogen atom, an alkyl group, a haloalkyl group, a halogen atom, a mercapto group, an alkylmercapto group, a hydroxy group, an alkoxy group, an acyloxy group, a carboxyl group, an alkoxycarbonyl group, an amino group, an alkyl-substituted amino group, an aryl-substituted amino group, an acylamino group, a haloalkoxycarbonylamino group, an alkanesulphonyl group, a nitro group or a cyano group (and, when n is an integer from 2 to 5, the radicals R.sup.1 may be the same or different);R.sup.2 and R.sup.3 may be the same or different and each is a hydrogen atom or an alkyl group;R.sup.4 is a hydrogen atom, an alkyl group, a cyano group, a cyanoalkyl group, a hydroxyalkyl group, an alkoxycarbonyl group, a carboxyl group, an aryl group, an aralkyl group, a mercaptoalkyl group, an alkylthioalkyl group, or a thioalkyl group (the free bond of the sulphur in said thioalkyl group being joined to the sulphur of another moiety of the same formula); andA is a hydroxy group, an alkoxy group, an amino group, an alkyl-substituted amino group (optionally halogen- or carbamoyl- substituted in the alkyl moiety), a hydrazino group, an alkyl- or aryl- substituted hydrazino group, a hydroxylamino group, an alkoxyamino group or an aralkyloxyamino group;and the pharmaceutically acceptable salts thereof.
    • 可用作免疫调节和抗肿瘤剂的新化合物是下式的氨基酸衍生物:其中:n是1至5的整数; R1是氢原子,烷基,卤代烷基,卤素原子,巯基,烷基巯基,羟基,烷氧基,酰氧基,羧基,烷氧基羰基,氨基, 烷基取代的氨基,芳基取代的氨基,酰氨基,卤代烷氧基羰基氨基,链烷磺酰基,硝基或氰基(当n为2至5的整数时,基团R 1可以 相同或不同); R2和R3可以相同或不同,各自为氢原子或烷基; R4是氢原子,烷基,氰基,氰基烷基,羟基烷基,烷氧基羰基,羧基,芳基,芳烷基,巯基烷基,烷硫基烷基或硫代烷基 (所述硫代烷基中的硫的游离键与相同式的另一部分的硫连接); 并且A是羟基,烷氧基,氨基,烷基取代的氨基(在烷基部分中任选被卤素取代或氨基甲酰基取代),肼基,烷基或芳基取代的肼基, 羟基氨基,烷氧基氨基或芳烷氧基氨基; 及其药学上可接受的盐。
    • 38. 发明授权
    • Benzodioxole derivatives and pharmaceutical use thereof
    • 苯并二恶醇衍生物及其药物用途
    • US4414214A
    • 1983-11-08
    • US369873
    • 1982-04-19
    • Ernst HabichtPaul Zbinden
    • Ernst HabichtPaul Zbinden
    • A61K31/357A61K31/36A61P7/10C07C45/46C07C45/67C07C45/68C07C49/84C07D317/46A61K31/335C07D317/68
    • C07D317/46C07C45/46C07C45/673C07C45/68C07C49/84Y10S514/869Y10S514/87
    • The invention relates to novel benzodioxole derivatives of the formula I ##STR1## in which R.sub.1 represents an unsubstituted or substituted, aromatic or heteroaromatic radical, alk represents an alkylene or alkylidene radical having a maximum of 5 carbon atoms, n represents 0 or 1, R.sub.2 and R.sub.3 each represents, independently of the other, hydrogen, lower alkyl, lower alkoxy or halogen, and A represents the radical O--R.sub.4, wherein R.sub.4 represents hydrogen or an unsubstituted or substituted, aliphatic or araliphatic hydrocarbon radical, or A represents the radical ##STR2## in which either R.sub.5 and R.sub.6 each represents, independently of the other, hydrogen or lower alkyl, or R.sub.5 and R.sub.6 are bonded to one another and, together with the adjacent nitrogen atom, represent unsubstituted or lower alkyl-substituted tetra- or hexa-methyleneimino or 4-morpholinyl, to salts of compounds of the formula I in which A represents OR.sub.4 wherein R.sub.4 is hydrogen, with bases, and to acid addition salts of compounds of the formula I in which the radical R.sub.1 has a basic character, and to pharmaceutical compositions that contain them. The novel substances exhibit diuretic and, in addition, uricosuric activity and may be administered, according to the invention, preferably in the form of appropriate pharmaceutical compositions, to mammals for the treatment of oedema and hypertension.
    • 本发明涉及式I(I)的新的苯并间二氧杂环戊烯衍生物,其中R 1表示未取代或取代的芳族或杂芳族基团,alk表示具有最多5个碳原子的亚烷基或亚烷基,n表示0或 1,R 2和R 3各自独立地表示氢,低级烷基,低级烷氧基或卤素,A表示基团O-R 4,其中R 4表示氢或未取代或取代的脂族或芳脂族烃基,或A 表示其中R 5和R 6各自独立地表示氢或低级烷基或R 5和R 6彼此键合并且与相邻的氮原子一起代表未取代或低级烷基取代的基团 四或六亚甲基亚氨基或4-吗啉基的化合物与式I化合物的盐,其中A表示OR4,其中R4是氢,具有碱,以及f的化合物的酸加成盐 其中基团R1具有基本特征的Ormula I,以及含有它们的药物组合物。 该新物质显示利尿剂,另外还包含尿酸活性,并且根据本发明可以优选以适当的药物组合物的形式给哺乳动物用于治疗水肿和高血压。